Designed for decisions that drive revenue, defend share, and uncover white space
declares having received consulting honoraria from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and AstraZeneca, and received research grants through his affiliation from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Rhythm
The data shows that semaglutide at the full weight loss dose has somewhat higher rates of nausea and vomiting compared to tirzepatide, though the comparison between semaglutide and tirzepatide side effects involves many variables beyond simple percentage comparisons
This gives you a clean 2.5mg/mL concentration where standard doses land on easy-to-read syringe markings
Although we see benefits, at what cost do the benefits come